Our history
The MEDICE success story began in Iserlohn in 1949. Today MEDICE is one of the leading SME healthcare companies in Germany and is also diversified internationally.
1949
Company foundation
Foundation of MEDICE in Iserlohn by Gustav Pütter, inventor of the Pütter bandage.
1953
Launch of Meditonsin®
Product launch of Meditonsin®, our natural cold remedy – since then proven a million times over in acute inflammation of the throat, nasal cavity and pharynx.
1977
Dr. med. S. Pütter joins the company
Dr. med. Sigurd Pütter, the 2nd generation of the family takes over management at MEDICE.
1989
Launch of nephrology drugs
Introduction of the successful ‘MEDICE nephrology’ range of drugs for renal patients.
2000
Launch of Medikinet®
Introduction of Medikinet® – medicinal product for multimodal therapy of ADHD.
2001
Dr. med. K. Pütter-Ammer joins
With Dr. med. Katja Pütter-Ammer, the 3rd generation of the family joins the company.
2003
Dr. med. Dr. oec. R. Ammer joins
Dr. med. Dr. oec. (Economics) Richard Ammer joins the company MEDICE as a further Managing Director.
2006
Acquisition of Rentschler
With the acquisition of Rentschler Arzneimittel, MEDICE completes further strategic expansion of its OTC business. Expansion of OTC products with successful brands like Dorithricin® for the treatment of sore throats and Tannacomp® for diarrhoea.
2007
Launch of Abseamed®
Launch of Abseamed® as the first biosimilar with the active pharmaceutical ingredient erythropoietin alfa (Epoetin) for the treatment of anaemia to be approved in the EU.
2011
Launch of Medikinet® Adult and Monofer®
Launch of Medikinet® adult, the first drug approved in Germany for the treatment of ADHD in adults. Launch of Monofer®, which allows a safe and high-dose infusion of iron as a single dose.
2012
E. Neyret joins
Eric Neyret joins MEDICE as new Managing Director for Finance, Controlling and Administration.
2012
Acquisition of Perenterol®
Acquisition of sales and distribution of Perenterol® against diarrhoea and for the prevention of travel diarrhoea.
2014
Dr. J. Kreimeyer joins
Dr. Jürgen Kreimeyer becomes the new Managing Director of MEDICE for Marketing & Sales and Medical Science (OTC).
2017
Launch of Attentin®
Launch of the first and only dexamfetamine finished medicinal product.
2019
Reconstruction of the MEDICE administration building
Completion of the new four-storey MEDICE administration building with 2,700 sqm of floor space.